deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT05621213

Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation (VNI_SLA)

Satisfaction of Patients With Amyotrophic Lateral Sclerosis Under Non-invasive Ventilation Regarding Home Assisted Teleconsultation

Sponsor: AGIR à Dom

Updated 5 times since 2022 Last updated: Feb 4, 2026 Started: Jan 13, 2023 Primary completion: Dec 31, 2024 Completion: Sep 5, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was terminated early due to insufficient recruitment despite mitigation measures, as enrolment rates could not meet protocol objectives. Academic thesis scheduling constraints also contributed. No safety concerns were identified.

Listed as NCT05621213, this NA trial focuses on ALS and Charcot Disease and remains terminated or withdrawn. Sponsored by AGIR à Dom, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotNot Yet Recruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotRecruiting~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotTerminated

Change History

5 versions recorded
  1. Feb 2026 — Present [monthly]

    Terminated NA

    Status: RecruitingTerminated

  2. Sep 2024 — Feb 2026 [monthly]

    Recruiting NA

  3. Aug 2024 — Sep 2024 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  4. Jul 2024 — Aug 2024 [monthly]

    Not Yet Recruiting NA

  5. Dec 2022 — Jul 2024 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AGIR à Dom
Data source: AGIR à Dom

For direct contact, visit the study record on ClinicalTrials.gov .